Heparizin – Phospholipid Complex
Composition: Each capsule contains:
Active ingredients: Glycyrrhizin – 50 mg; Glycine – 50 mg; DL-Methionine – 50 mg; Phospholipids – 217 mg (equivalent to 65 mg of phosphatidylcholine).
Recommendations for Use: To be used as recommended by a physician as an additional source of the essential sulfur-containing amino acid methionine and natural biologically active components:
Purpose:
Benefits of Phospholipids in Heparizin® PLC:
The phospholipids in Heparizin® PLC are chemically similar to endogenous phospholipids but surpass them due to a high content of polyunsaturated (essential) fatty acids. These high-energy molecules integrate primarily into cellular membrane structures, promoting the restoration of damaged liver tissues.
Phospholipids regulate lipid metabolism by influencing lipoprotein metabolism, converting neutral fats and cholesterol into transportable forms. During phospholipid excretion through the biliary tract, the lithogenic index decreases, stabilizing bile.
Additionally, phospholipids enhance the lipophilic properties of glycyrrhizic acid, increasing its absorption rate and intensity by more than 2 times.
Method of Administration and Recommended Daily Dose: Adults are recommended to take 1 capsule 3 times daily after meals.
Contraindications:
More about the product:
You find yourself in a specialized publication, which is part of the site of Valatin Pharma LLC and is intended for medical institutions and doctors (the “certified medical specialists”) and contains professional specialized information about medicines, including prescription medicines, in particular, about their name, characteristics, methods of application, medicinal properties, possible side effects, possible contraindications, and other professional specialized information.
Information about preparations, including prescription medicines of PJSC Pharmaceutical company Darnitsa, is intended solely for familiarizing and is not a guide for self-diagnosis or treatment.
Can you confirm that you have read this restriction on receiving information and you are a medical professional or doctor?